Testosterone therapy for women with low androgen levels or body weight
2 April 2004. Related: Conference reports, Women's health.
Conference reports
Nevirapine, pregnancy and adverse events
2 April 2004. Related: Conference reports, Pregnancy.
Prior nevirapine exposure for pregnant women can contribute to treatment failure
2 April 2004. Related: Conference reports.
Conflicting findings with HAART use in pregnancy and prematurity
2 April 2004. Related: Conference reports, Pregnancy.
Antiretrovirals, mode of delivery and transmission risk
2 April 2004. Related: Conference reports, Pregnancy.
Tenofovir studies in children
2 April 2004. Related: Conference reports, Paediatric care.
Increase of non-AIDS defining cancers in HOPS cohort
2 April 2004. Related: Conference reports, Cancer and HIV.
HIV/HCV coinfection: superiority of pegylated interferon plus ribavirin, but lower response rate compared to mono-infected patients, especially for genotype-1
2 April 2004. Related: Conference reports, Hepatitis coinfection.
Epoetin-alfa improves interferon/ribavirin-associated anaemia
2 April 2004. Related: Conference reports, Hepatitis coinfection.
9th European AIDS Conference (EACS), 25-29 October 2003, Warsaw
1 December 2003. Related: Conference reports.
Lower doses of d4T produce similar efficacy and reduced side effects
1 December 2003. Related: Conference reports, Side effects, Weight, diabetes, metabolic complications.
Switching from efavirenz to nevirapine to avoid CNS side effects
1 December 2003. Related: Conference reports, Antiretrovirals, Side effects.
Interruption of treatment is safe for those who started too early
1 December 2003. Related: Conference reports, Treatment strategies.
T20 is cost effective for UK purchasers
1 December 2003. Related: Conference reports, Antiretrovirals.
Intrauterine exposure to efavirenz
1 December 2003. Related: Conference reports, Women's health, Pregnancy, Side effects.
African patients and adherence in the UK
1 December 2003. Related: Conference reports, Antiretrovirals.
Five-year results of Kaletra-based therapy in treatment-naïve HIV patients
1 December 2003. Related: Conference reports, Antiretrovirals.
IL-2 effectively increases CD4 count in people with low CD4 nadir
1 December 2003. Related: Conference reports, Basic science and immunology.
Hepatitis coinfection: incidence in Europe and response to transplant
1 December 2003. Related: Conference reports, Hepatitis coinfection.
Rituximab plus CDE for HIV-related Non-Hodgkins Lymphoma (NHL)
1 December 2003. Related: Conference reports, Antiretrovirals, Cancer and HIV.
13th International Conference on AIDS and STIs in Africa (ICASA), 21-26 September 2003, Nairobi
1 November 2003. Related: Conference reports.
STIs in resource limited settings
1 November 2003. Related: Conference reports, Treatment strategies.
43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 14-17 September 2003, Chicago
1 November 2003. Related: Conference reports.
ddI may retain activity in nucleoside experienced patients
1 November 2003. Related: Conference reports, Antiretrovirals.
Studies and strategies with existing drugs
1 November 2003. Related: Conference reports, Antiretrovirals, Treatment strategies.
Incremental progress with new antiviral drugs
1 November 2003. Related: Conference reports, Antiretrovirals.
Newer nucleoside analogues show fewer adverse effects
1 November 2003. Related: Conference reports, Side effects.
43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 14-17 September 2003, Chicago
1 October 2003. Related: Conference reports.
South African AIDS Conference, 3-6 August 2003, Durban
1 October 2003. Related: Conference reports.
Township project is a model for care in resource poor settings
1 October 2003. Related: Conference reports, Treatment access.
Projects band together to buy lowest-cost generic drugs
1 October 2003. Related: Conference reports, Treatment access.
MTCT-Plus operates in Cote D’Ivoire, Kenya, Mozambique, Rwanda, South Africa, Thailand, Uganda and Zambia
1 October 2003. Related: Conference reports, Pregnancy.
Further reports from 2nd IAS Conference on HIV Pathogenesis and Treatment, Paris, 13-16 July 2003
1 October 2003. Related: Conference reports.
New atazanavir information
1 October 2003. Related: Conference reports, Antiretrovirals.
Boosted PI therapy antiretrovirals in treatment-experienced patients: SQV/r, ATV, ATV/r
1 October 2003. Related: Conference reports, Antiretrovirals.
HIV viral dynamics: viral fitness, genetic diversity, progression, co-receptor use
1 October 2003. Related: Conference reports, Basic science and immunology, Virology.
Pulmonary hypertension: finally a treatment trial!
1 October 2003. Related: Conference reports, Virology.
XII International HIV Drug Resistance Workshop, Los Cabos, Mexico, 10-14 June 2003
1 September 2003. Related: Conference reports, Drug resistance.
Transmission of drug resistance – at 11% in Europe and 17% in the UK
1 September 2003. Related: Conference reports, HIV prevention and transmission, Drug resistance.
HIV coinfection, reinfection and superinfection
1 September 2003. Related: Conference reports, Hepatitis coinfection, HIV prevention and transmission, Drug resistance.
Single-dose nevirapine resistance in over 75% of mothers
1 September 2003. Related: Conference reports, Women's health, Pregnancy, Drug resistance.
Transmission of drug resistant virus does not revert to wild-type and does not appear ‘less fit’
1 September 2003. Related: Conference reports, Drug resistance.
Standard genotype assays may miss 75% of mutations when present in less than 35% of plasma sample
1 September 2003. Related: Conference reports, Drug resistance.
Low-level resistance and minority populations: cross resistance between nevirapine and efavirenz occurs even in the absence of genotypic mutations found using population sequencing
1 September 2003. Related: Conference reports, Drug resistance.
Persistent effect of d4T and 3TC, but not NNRTIs in the presence of associated genotypic mutations
1 September 2003. Related: Conference reports, Drug resistance.
Replicative capacity results complicated by minority wild-type virus
1 September 2003. Related: Conference reports, Virology, Drug resistance.
Tenofovir, resistance and K65R and concomitant nucleosides
1 September 2003. Related: Conference reports, Antiretrovirals, Drug resistance.
Response to STI is determined by virus rather than immunological response
1 September 2003. Related: Conference reports, Drug resistance.
Why resistance rarely develops with viral suppression <50 copies/mL
1 September 2003. Related: Conference reports, Drug resistance.
Long-term persistence of distinct mutations in genital tract
1 September 2003. Related: Conference reports, Women's health, Drug resistance.
5th International Workshop on Adverse Drug Reactions and Lipodystrophy, 8-11 July 2003, Paris
1 September 2003. Related: Conference reports, Weight, diabetes, metabolic complications.
Underlying mechanisms: adipocytes and cytokines
1 September 2003. Related: Conference reports, Weight, diabetes, metabolic complications, Basic science and immunology.
More mitochondrial DNA depletion
1 September 2003. Related: Conference reports, Weight, diabetes, metabolic complications.
IMT and cardiovascular risk
1 September 2003. Related: Conference reports, Weight, diabetes, metabolic complications.
Reduced bone mineral density in HIV-positive women
1 September 2003. Related: Conference reports, Weight, diabetes, metabolic complications.
Rosiglitazone with insulin resistance
1 September 2003. Related: Conference reports, Side effects, Weight, diabetes, metabolic complications.
Additional benefits of exercise with metformin
1 September 2003. Related: Conference reports, Weight, diabetes, metabolic complications.
Mitochondrial toxicity with AZT and d4T – and benefits of switch to abacavir
1 September 2003. Related: Conference reports, Antiretrovirals, Weight, diabetes, metabolic complications.
Facial fat loss – measuring and treatment
1 September 2003. Related: Conference reports, Treatment access, Weight, diabetes, metabolic complications.
Uridine treatment for mitochondrial toxicity
1 September 2003. Related: Conference reports, Side effects, Weight, diabetes, metabolic complications.
Breast enlargement in men and testosterone treatment
1 September 2003. Related: Conference reports, Weight, diabetes, metabolic complications.
Severe efavirenz psychotic events
1 September 2003. Related: Conference reports, Side effects.
Treatment interruption: a real choice
1 September 2003. Related: Conference reports, Treatment strategies, Weight, diabetes, metabolic complications.
2nd IAS Conference on HIV Pathogenesis and Treatment, 13-16 July 2003, Paris
1 September 2003. Related: Conference reports.
Nevirapine and MTCT: the single-dose backlash
1 September 2003. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy, Paediatric care.